Home › Trial NCT02986867
SAbR Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical Carcinoma
- Trial IDNCT02986867
- StatusCompleted
- PhaseN/A
- Study typeInterventional
- SponsorUniversity of Texas Southwestern Medical Center
- Enrollment27
- Start date2017-06-13
- ConditionsUrothelial Carcinoma · Melanoma · Cervical Carcinoma in Situ
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.